Samantha Sigurdson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samantha Sigurdson has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Anja C. Roden
5 shared publicationsConrad B. Falkson
Department of Oncology, Queen's University, Cancer Centre of Southeastern Ontario, Kingston, ON, Canada
4 shared publicationsEdith M. Marom
4 shared publicationsArun Rajan
3 shared publicationsFrank C. Detterbeck
Department of Surgery, Yale University, New Haven, CT, USA
3 shared publicationsMalgorzata Szolkowska
3 shared publications
Latest Publications
- Open Access
- 1 December 2022
- Published by AME Publishing Company in Mediastinum
- Vol. 6, 40
The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report
Case Report The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report Samantha Sigurdson, Edith M. Marom, Andreas Rimner, Annemarie Shephard, Malgorzata Szolkowska, Anja C. Roden, Mirella Marino, Noriyuki Tomiyama, David Ball, Conrad Falkson, Arun Rajan
- 1 December 2022
- Published by AME Publishing Company in Mediastinum
- Vol. 6, 40
Open AccessThe therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report
Case Report The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report Samantha Sigurdson, Edith M. Marom, Andreas Rimner, Annemarie Shephard, Malgorzata Szolkowska, Anja C. Roden, Mirella Marino, Noriyuki Tomiyama, David Ball, Conrad Falkson, Arun Rajan
- Open Access
- 1 March 2020
- Published by AME Publishing Company in Mediastinum
- Vol. 4, 7
Case presentations and recommendations from the 2018 ITMIG Annual Meeting
The 9th International Thymic Malignancy Interest Group’s (ITMIG) Annual Meeting was held in Seoul, South Korea in October 2018, and in this article, we discuss three of the cases presented and review the radiology imaging and pathology slides. The first two cases involve thymic carcinoma: the first reviews systemic therapy recommendations for non-resectable recurrence and the second case the optimal treatment recommendations after incomplete resection. The third case discusses treatment recommendations for recurrent thymoma after complete resection.
- 1 March 2020
- Published by AME Publishing Company in Mediastinum
- Vol. 4, 7
Open AccessCase presentations and recommendations from the 2018 ITMIG Annual Meeting
The 9th International Thymic Malignancy Interest Group’s (ITMIG) Annual Meeting was held in Seoul, South Korea in October 2018, and in this article, we discuss three of the cases presented and review the radiology imaging and pathology slides. The first two cases involve thymic carcinoma: the first reviews systemic therapy recommendations for non-resectable recurrence and the second case the optimal treatment recommendations after incomplete resection. The third case discusses treatment recommendations for recurrent thymoma after complete resection.
- Open Access
- 1 December 2019
- Published by AME Publishing Company in Mediastinum
- Vol. 3, 41
Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team
Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team
- 1 December 2019
- Published by AME Publishing Company in Mediastinum
- Vol. 3, 41
Open AccessCase presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team
Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team
- Open Access
- 1 January 2019
- Published by AME Publishing Company in Mediastinum
- Vol. 3, 4
Case presentation and recommendations from the April 2018 ITMIG tumor board: an international multidisciplinary team
The International Thymic Malignancy Interest Group (ITMIG) has periodic tumor board meetings to discuss challenging cases. The case of a pediatric thymoma from the April 2018 meeting is discussed in this article. Radiology imaging and pathology slides are reviewed. Treatment and surveillance recommendations are discussed, as well as lessons learned from group discussion.
- 1 January 2019
- Published by AME Publishing Company in Mediastinum
- Vol. 3, 4
Open AccessCase presentation and recommendations from the April 2018 ITMIG tumor board: an international multidisciplinary team
The International Thymic Malignancy Interest Group (ITMIG) has periodic tumor board meetings to discuss challenging cases. The case of a pediatric thymoma from the April 2018 meeting is discussed in this article. Radiology imaging and pathology slides are reviewed. Treatment and surveillance recommendations are discussed, as well as lessons learned from group discussion.
- 1 September 2018
- Published by AME Publishing Company in Mediastinum
- Vol. 2, 53
Case presentations and recommendations from the October 2017 ITMIG tumor board: an international multidisciplinary team
The International Thymic Malignancy Interest Group (ITMIG) has periodic tumor board meetings to discuss perplexing cases. Two of these cases from the October 2017 meeting are discussed in this article. The diagnoses of a simple thymic cyst and a thymoma are confirmed. Radiology imaging from both cases and pathology slides from the thymoma are reviewed. Treatment and surveillance recommendations are discussed for both cases, as well as lessons learned from group discussion.
- 1 September 2018
- Published by AME Publishing Company in Mediastinum
- Vol. 2, 53
Case presentations and recommendations from the October 2017 ITMIG tumor board: an international multidisciplinary team
The International Thymic Malignancy Interest Group (ITMIG) has periodic tumor board meetings to discuss perplexing cases. Two of these cases from the October 2017 meeting are discussed in this article. The diagnoses of a simple thymic cyst and a thymoma are confirmed. Radiology imaging from both cases and pathology slides from the thymoma are reviewed. Treatment and surveillance recommendations are discussed for both cases, as well as lessons learned from group discussion.